Gevokizumab Terminated Phase 3 Trials for Behcet's Disease Uveitis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02258867Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis